Agenda for Day Two - Wednesday November 18th, 2026 - EST
- Prakash Chainani - Senior Vice President – Finance, HR and IT, Lifestar Pharma LLC (a Mankind Group Company)
- Explore real-world AI use cases across GTN operations, including rebate and chargeback validation and contracting simulation
- Explore accessible Generative AI tools that streamline GTN operations with scenario modeling, integrated forecasting and real-time dashboards
- Discuss implementation strategies, change management, and lessons learned, including data quality, system integration, organizational silos and ROI measurement
- Address AI governance and compliance, including maintaining human oversight in decision making, audit trails and SOX implications for AI-driven financial processes and regulatory reporting
CPE Credits Available: 1.0
- Tom Evegan - Principal, Strategy & Management Consulting, RSM US LLP
- Patrick Sipple - Director, AI Policy & Channel, Bristol Myers Squibb
- Ryan Coelho - Former Director, Net Revenue Management, Zoetis
Get an exclusive front-row seat to short demos from leading vendors unveiling their latest innovations and strategic breakthroughs that are reshaping the gross-to-net landscape.
- Timothy Bonn - Senior Director, Gross to Net, Breakaway Technologies
- Romit Kamdar - Partner, Akara Group LLC
- Eduardo Goncalves - CEO, Kernel Solutions
- Josh Gingerich - Chief Customer Success Officer, Kernel Solutions
- Marcus Bourget - Customer Success Officer, Kernel Solutions
- Develop reimbursement strategies, optimize distribution channels, and bridge revenue gaps across commercialization stages while managing cash flow constraints and limited resources
- Execute production launch strategies, maximize negotiation leverage, structure contracting dynamics, build 3PL/distributor relationships, and create agreements that support growth objectives
- Implement forecasting methodologies for early-stage assets and launch brands, plan scenarios with limited data, manage volume projection uncertainty, and build flexible models that adapt as real-world data emerges
CPE Credits Available: 1.0
- Neel Shah - Managing Director, Gross-to-Net, Riparian
- Elizabeth Rodriguez - Director, Revenue, Akebia Therapeutics, Inc.
- Kinneret Klein - Executive Director, Commercial Financial Planning & Analysis, Biocryst
- Hear MFP lessons learned from 11 months of actualization and implementation, address rebate model complexities, and adapt strategies based on real-world experience
- Discuss other government pricing challenges around Medicaid, 340B, MFN, etc. and best practices to address an ever-evolving landscape
- Manage SOX compliance requirements, coordinate across legal/compliance/commercial teams, and maintain audit-ready documentation throughout implementation
- Execute system configuration updates, document process requirements, and manage timelines for operationalizing government pricing changes effectively
CPE Credits Available: 1.0
- Hilary Sherman - Independent, Independent
- Josephine Hawkins - Director, Medicaid, AstraZeneca
- Timothy Kocses - Executive Director, US Commercial Finance Controller, Bristol-Myers Squibb
- Address revenue recognition challenges, navigate complex GTN scenarios, ensure ASC 606 compliance, and refine variable consideration estimates
- Optimize month-end close processes, streamline GTN accruals, enhance provision accuracy, and improve reconciliation workflows
- Maintain SOX compliance and internal controls, fulfill documentation requirements, conduct control testing, and ensure audit preparedness specific to GTN
- Foster cross-functional collaboration, work effectively with commercial, legal, and IT teams, and align GTN operations across departments
- Leverage systems integration opportunities, configure ERP systems, optimize data flows, and implement automation solutions
CPE Credits Available: 1.0
- Michael Grosberg - Vice President, Product Management, Model N
- James Engel - Controller, Finance, Collegium Pharmaceuticals
- Rohit Gupta - Senior Director, Commercial Finance, Crinetics Pharmaceuticals
- Quantify how payer landscape dynamics, formulary positioning, and access restrictions impact GTN forecasting accuracy, revenue projections, and rebate accruals through practical financial modeling frameworks
- Master GTN implications of value-based, outcomes-based, and installment contracts including ASC 606 revenue recognition, variable consideration treatment, and forecasting methodologies for complex arrangements
- Develop financial models to evaluate P&L impact of PBM contracting scenarios, forecast rebate escalations, calculate GTN provisions, and conduct sensitivity analysis to support strategic negotiations
- Understand GTN financial implications of copay assistance and patient access programs including revenue recognition treatment, accrual methodologies, forecasting approaches, and financial statement impact
- Build collaborative frameworks for integrating market access strategies with GTN finance operations including scenario planning, financial modeling for contracting decisions, and cross-functional alignment
CPE Credits Available: 1.0
- Tom Travaglini - Manager, RSM Life Sciences Advisory
- Ranish Singhvi - Vice President, Finance, Accord Healthcare
- Eric Kimelblatt - Executive Director, Market Access Payer and Contract Strategy, Compass Pathways
- End-to-end processing from Inmar return data through validation, approval, and SAP credit memo creation
- Customer-specific pricing and policy rules applied at line level to support accurate return-credit calculation
- Configurable validation across customer, product, batch, sales, and return data to identify exceptions and potentially non-returnable products
- Automated approval workflows and rejection handling based on defined business rules and Return Goods Policy requirements
- Daily processing of Inmar files with reduced manual intervention, rework and processing delays
- SAP integration for credit memo creation, with document status and reference information returned to the workflow
- Greater pricing accuracy, stronger control, and reduced return-related financial leakage, with visibility from claim through settlement
- K. C. Sahu - CEO, ITRadiant
- Fred Mariash - Associate Director, Accounts Receivable, Hikma Pharmaceuticals
Prepare your organization for the evolving GTN landscape with actionable strategies and forward-looking insights:
- Discuss a practical action planning roadmap for implementing learnings upon return to your organization, including prioritization strategies, stakeholder engagement approaches, and quick-win opportunities to demonstrate immediate value
- Explore how to build high-performing cross-functional GTN teams
- Analyze emerging trends & 2027 outlook, including forward-looking analysis of anticipated regulatory developments, technology innovations, and market dynamics that will shape GTN strategy in the coming year, with guidance on proactive preparation
CPE Credits Available: 1.0
- Patrick Coyle - Founder and CEO, Novus Proximus
- Prakash Chainani - Senior Vice President – Finance, HR and IT, Lifestar Pharma LLC (a Mankind Group Company)
- Matt Pellegrini - Former Senior Director - Contract Operations N.A., Formerly Teva Pharmaceuticals
Dive deep into the GTN complexities specific to your product portfolio in these interactive, facilitator-led roundtables. Whether you manage Brand/Biologic or Generic products, you'll collaborate with industry peers facing similar GTN challenges. This focused format will provide relevant, high-impact discussions that address the distinct dynamics of each product type, including topics such as product-specific forecasting methodologies, channel dynamics, regulatory considerations, rebate structures, and operational best practices.
Interactive roundtables will be focused on: Brand/Biologics and Generics.
CPE Credits Available: 1.0
- Ivorita Foster - Director, Gross to Net - Finance, Sandoz
- Prakash Chainani - Senior Vice President – Finance, HR and IT, Lifestar Pharma LLC (a Mankind Group Company)
